Driven by government regulations, market pressures, and the need for sustainable growth, pharmaceutical manufacturers are seeking advanced 100% testing solutions. These solutions must be precise, fast, and cover all stages—from raw materials and excipients to process monitoring and final inspections. Raman spectroscopy, recognized by pharmacopoeias, is a key enabler of drug development and quality control.

The JINSP RS1000DI drug identification instrument is a state-of-the-art device designed to ensure the highest standards of quality and safety in pharmaceutical manufacturing. It is capable of performing a meticulous 100% package-by-package inspection of raw materials and packaging materials, a process that is critical for maintaining the integrity of the drug production chain. This sophisticated instrument can quickly and accurately identify raw materials in various environments, including warehouses, material preparation rooms, and production workshops, where efficiency and precision are paramount.

The RS1000DI's advanced technology not only meets but exceeds the rigorous requirements of FDA 21 CFR Part 11, a regulation that sets the standard for electronic records and signatures in the pharmaceutical industry. Additionally, it adheres to the guidelines of Good Manufacturing Practice (GMP), ensuring that every product that leaves the facility meets the highest quality benchmarks. We, at JINSP, are deeply committed to the success of our clients and the safety of patients worldwide. In line with this commitment, we provide comprehensive technical support services that encompass method establishment, verification, and 3Q certification.